Mike Hausladen

Mike Hausladen is the General Manager of Lotte Biologics USA, LLC, a subsidiary of LOTTE Biologics. He has been in this role since November 2022.1 Here are some key details about Mike Hausladen:

Professional Background

• Hausladen has over 25 years of experience in commercial and clinical manufacturing of cell therapies, biologics, pharmaceuticals, and fine chemicals.1
• Before joining Lotte Biologics, he spent much of his career with Bristol Myers Squibb, starting at their East Syracuse plant in 2001.1

Current Role and Responsibilities

As General Manager of Lotte Biologics USA, Hausladen is responsible for:

• Overseeing the operations of Lotte's drug substance manufacturing site in East Syracuse, New York.1
• Managing a workforce of approximately 450 people at the Syracuse plant.1
• Spearheading a $48 million expansion project to transform the facility into one of North America's top ADC (Antibody-Drug Conjugate) manufacturing facilities.1

Vision and Strategy

Hausladen is committed to supporting Lotte Biologics' ambitious goals:

• He aims to contribute to Lotte's objective of becoming a global top 10 CDMO (Contract Development and Manufacturing Organization) company by 2030.1
• Hausladen sees significant potential in leveraging the Syracuse site's proximity to Boston, a major biopharmaceutical hub, to expand contract development and manufacturing services.1

Leadership Style

Hausladen is described as a leader with a growth mindset and a successful history of bringing people together.2 His extensive experience in the industry and his commitment to Lotte's vision make him a key figure in the company's expansion plans in the United States.